Close

Bora Pharmaceutical makes strategic appointment to strengthen global manufacturing capabilities

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Oncology start-ups urged to apply and accelerate their business with Discovery Spark

Applications open for Discovery Park’s oncology themed ‘Discovery...

2025 AI Trends & Pharma Predictions

As we navigate what the future of healthcare will...

Swiss Airtainer reaches major milestone with successful completion of first 50 commercial shipments

Swiss Airtainer is pleased to announce the successful completion of its first 50 commercial shipments of high-value life science...

Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO), has appointed Don Liscombe as their Vice President and General Manager to lead its flagship manufacturing facility in North America, located in Mississauga,  Ontario, Canada.

Don will be responsible for leading the ambitious growth plans for the Mississauga facility and its  current 400 strong workforce. Bringing a wealth of experience in pharmaceutical operations and the  contract manufacturing industry, Don is recognized for driving profitable growth through customer  service, employee engagement and a commitment to operational excellence. He has held  progressively senior roles in the industry, including General Manager and most recently as leader of  Regional Operational excellence at a global CDMO.

Commenting on his appointment, Don Liscombe said “I am privileged to serve in an industry that  has a profound impact on people’s lives, and I am honoured to join the Bora team whose mission is  “Contributing to Better Health All Over the World”.

“I am impressed by the company’s track record of delivering top-tier services to their customers and  I am truly excited to be joining them at a time of significant growth to reach more patient around the  world”.

Bobby Sheng, CEO of Bora Pharmaceuticals commented; “we are delighted to be in a position to  attract a leader like Don into the organization, he brings invaluable CDMO knowledge and  experience to the team, and will help drive us towards our impressive growth strategy.

Latest stories